United States Microcarriers Market Size, Share, and COVID-19 Impact Analysis, By Consumable (Media & Reagents and Microcarrier Beads), By Application (Biopharmaceutical Production and Regenerative Medicine), and United States Microcarriers Market Insights, Industry Trend, Forecasts to 2035

United States Microcarriers Market Insights Forecasts to 2035

• The US Microcarriers Market Size Was Estimated at USD 633.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 10.74% from 2025 to 2035
• The US Microcarriers Market Size is Expected to Reach USD 1944.9 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The United States Microcarriers Market Size is anticipated to reach USD 1944.9 Million by 2035, Growing at a CAGR of 10.74% from 2025 to 2035. The expansion of the United States microcarriers market is propelled by significant financial outlays for the creation of novel treatments, and steady technological developments in cell biology research

Market Overview

A microcarrier is a support matrix, typically small, spherical beads ranging in diameter from 100 to 300 μm, that allow the growth of anchorage-dependent cells in stirred bioreactor systems instead of flat, two-dimensional cultures. The strong need for cell-based vaccinations and treatments is driving the market for microcarriers. Since they offer more effective and focused treatments for a variety of diseases, such as cancer and infectious diseases, cell-based vaccines and therapies are becoming more and more popular. Factors driving this growth are the increasing use of microcarriers in cell-based vaccine production, new technologies to deliver cell production involving the utilization of microcarriers, increased funding related to research in cell and gene therapies, a preference for single use technologies, as well as an increase in expenditures on research and development offered by biopharmaceutical production companies. For example, in August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic partnership. This strategic partnership is aimed at supporting Poseida’s efforts to further develop cancer cell therapy and is further demonstrating the increasing utilization of microcarriers in the US due to an increase in the chronic disease patient population, as well as the various cell and gene therapies being approved.

The National Institutes of Health (NIH) and the Advanced Regenerative Manufacturing Institute (ARMI) are two organisations that frequently get substantial funding from the U.S. government for research into cell culture technologies, including microcarriers.

Report Coverage

This research report categorizes the market for the United States microcarriers market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States microcarriers market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States microcarriers market.

Driving Factors

The growth of the United States microcarriers market is boosted by cell-based vaccines, gives yield higher efficacy than traditional egg-based vaccines, particularly when targeting virus strains. The ability to produce these vaccines at a faster pace is vital, especially because during pandemics, time is of the utmost essence. Microcarriers will further enhance the manufacturing practices by allowing for the mass production of the cells needed to produce the myriad treatments and vaccines available. Furthermore, microcarrier systems of production have a cost advantage since they are efficient and can be scaled. Cell-based vaccines and treatments that are less expensive will enhance accessibility for everyone. This also continues to drive the potential future growth of the microcarriers market.

Restraining Factors

The United States microcarriers market faces obstacles like the high cost of all raw materials. There is sophisticated manufacturing processes required to generate serum-free media, which is done with high purity and quality. The high start-up costs of serum-free media can dissuade companies from adopting a microcarrier process.

Market Segmentation

The United States microcarriers market share is classified into consumable and application.

• The microcarrier beads segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States microcarriers market is segmented by consumable into media & reagents and microcarrier beads. Among these, the microcarrier beads segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by the growing use of microcarrier beads during cell culture. The growth market in basic cell biology, the demand in regenerative medicines & biopharmaceuticals, and many microcarrier beads can be used for a variety of applications have led to significant growth in the market.

• The biopharmaceutical production segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the application, the United States microcarriers market is segmented into biopharmaceutical production and regenerative medicine. Among these, the biopharmaceutical production segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by the rising rates of infectious diseases & genetic disorders, and the higher incidence of cancer has increased the demand for producing safe & effective therapies or medicines. Biopharma companies are expanding their capacities and product offerings to fulfill this need.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States microcarriers market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Corning Incorporated
• Bio-Rad Laboratories Inc
• Danaher Corp
• Thermo Fisher Scientific Inc
• BD
• Entegris
• G&G Technologies
• PBS Biotech
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States microcarriers market based on the following segments:

United States Microcarriers Market, By Consumable

• Media & Reagents
• Microcarrier Beads

United States Microcarriers Market, By Application

• Biopharmaceutical Production
• Regenerative Medicine